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Tel “n.rhomer. Isroe, 
‘the signlficancc of mltecedmt angina in predicting clinical o”t- 
come was zwssed in 8,329 patimts wit\ x”te myocsrdiat infew 
../ rhmmbotytic therapy with either recombinant 
_+ :.+wnino~e” activator or rtreptaktnasr. There Were 
2,370 pstimis with antecedent &“a For il ;;.~a!& 1.512 
patients with antecedent angina for Cl month and 4.447 patio& 
Gth ne antecedent angina. The toncer the duration of andne, the 
worse tke baseline ciwactorisiia in the three groups: the mea” 
patient age was 65 versus 62 versus 61 years, nspectivcly (p < 
O.OO+lj; the rate of previous myocnrdial infarction was 37% 
versus tS% YPPSUS 10% (p < 0.0001): and the rate of hypertension 
WBE 40% “Eld”I 31% “W.i”S 27% ,p < @.0001). 
Antedent angka was asrocinted with a longer hospital stay 
(11Jand ll.idaysvs. lO.Sdays,p~0.000l),ahi~~rincid~nce 
Dib~p~Ewrwy!2.2% M.1.2%“~.0.7%,p=0.0001l,nwoM 
Fillip class at dlschherge (10.6% of patients ir, class 21 vs. 8.7% 
7s. 6.46, p = O.OiIOl), and a higher hmpital and 6.month 
morlsltty (12.1% and 18% vs. 8.9% and 11.6% vs. 6.6% and 
9.2%, rerpwtivety, p < O.w(I,,. 
A multivariate anolwis tatdne into acc”““t all ba.wllnr char- 
acteristirr conftrmed the indepe~dant aswiation of antecdpat 
angina with mortality, with a relative risk of 1.4 to 1.47 (p c 
0.0011. An&edent angina predtcts aW(IM clinical oa!cax”e and a 
more intense “se of medical resowas in patients with mute 
mywsrdial infarction receiving thrombdytir therapy. 
(I Am Cofi CanfM 1992;tO:36-41) 
Tho imp~w”cs of noninvasive predictors of patient ““t- 
come has increased because of recent studies (l-5) showing 
that conservative ma”ageme”f is associated with good out- 
come in patients with ac”fe myacardial infarction who 
receive thrombolytic therapy. Rontine coronary angiogra- 
phy is performed less often; instead. clinic”1 asses~r~e”ts 
and noninvasive predictors of patient outcome are used to 
monitor patient stat”s (Z-4). The prognostic significance of 
antecedent angina in this regard is controversial. Several 
studies (6-12) report hat antecedent angina predicts a worse 
outcome m patients with myocardial infarction, and two 
iant studies (13.14) found that antecedent anguta is a 
useful predictor ofresidual stenosts of the Infarct arterv after 
thrombolytic therapy. I” contrast, other investigatory (IS- 
17) have reported that patients with antecedent angina have 
better preservation of left vemnc”Iar function and better 
clinical ~wzon~e. However, only a few studies (IO-13,lg) 
have focused on patients with ac”te i”faxtion ?vhc received 
thrombolytic therapy. 
Because antecedent angina pectoris may he helpfui tar 
identifying high risk patients who “lay warrant more aws- 
sive post-thrombolytic management, we retrospectively an- 
alyzed the predictive significance of antecedent angina with 
respect to in-hospital and bmonth follow-up in the 8,329 
non-GISSI patients in the international tissue-type plas- 
minogen activatorlstreptokinase mortality study (19). 
Methods 
Study group. From October 1988 tc Aagttst 1989. 8,329 
consecutive patients with acute evolving myocardial infarc- 
tion were randomized to receive either ecombinant issue- 
type plasminogen activator @t-PA) or strep!okinase with or 
withwt subcutaneous heparin. Hence, there were four treat- 
ments in this open trial-streptokinase alone, streptokinase 
plus heparin, It-PA alone and rt-PA plus heparin. The 
proportiails of paiiads without antecede”: angina. with iI 
month antecedent angina and with >I month antecedent 
angina were eqsal in the four treatment arms. The study 
design, the inclusicn and exclusion criteria, the trial medi- 
cations and .he recommended treatments have been de- 
scribed in detail elsewhere (1’1.20). 
Although this was a pas: hoc analysis. data regarding 
antecedent angina were prospectively collected with use of 
case-record forms. The trial prolocol was approved by the 
Institutional Human Research Review Committees before 
initiation of the trial in October 1988 xd pvticipating 
patients gave informed consent. 
Statistical sodpis. Stztis’ica! analyw were o-rtormed 
with use of the Riomedical Cornouter Pmcrams (Bhli)W 
software. Univariate comparisons between tiIe groups were 
performed with chi-square analysis for trends for categoric 
variables ztd by analysis of variance (ANOVA) for contin- 
uous variables. 
A mtdtivatiate analysis with the logistic regrewon model 
(BMDP program LR) was conducted to identify variables 
associated with increased use ofmedical resources (length of 
hospitalization, coronary attgiaplasty. coronary bypass sur- 
gery) or mortality. This analysis took into account the 
following variables: age, gender. smoking history. hirlory of 
angina psrturis, previous acute myocardial infarction or 
diabetes mellitus, time from onset of acute myocardial 
infarction to treatment, systolic blood pressure and Killip 
classification at admission. The variables that independently 
predict the end points are presented as relative risks fol- 
lowed by 95% coniidence limits. 
Results 
Patient characteristics. Eight thousand three hundred 
twenty-nine patients with acute evolving myocardial infarc- 
tion received either intravenous r&PA or streptokinase. Of 
this group. 2.370 patients had had antecedent angina for >I 
month. 1.512 patients had had it for cl montii and 4,447 
patients had had no antecedent rpina. 
The baseline charactetistics of these three patient groups 
are presented in Table 1. Patients with a longer history of 
angina were older (G5 + IO years) than those with a shorter 
hidory (62 ? II years) or no history of angina (61 * II 
vears) (D < 3.CHJOI). Thev also had a hipher incidence of 
&vi& mfarction~(37%avs. 18% VI. :&, p < O.tXX!;, 
hypenen.ion (40% vs. 31% vs. 27%, p < O.wOI), diabetes 
melbtus (15% vs. 12% vs. 9%, p < O.wOi) and nypexholes- 
hrolemia than those with recent onset angina or no angina. 
Patierns with a longer history of angira were significantiy 
less likely to be smokers than were patients in dtetwo other 
groups. Althougb the time from onset of symptoms to the 
initiation of thrombolytic infusion was similar for all three 
patient groups, patients with a Iottger history of angina 
pectons star!ed with B significantly worse hcmodynamic 
stattts, as ixdicated by their Killip classification on admis- 
sion. 
CliGal course. During. the ho&al stay coronary aogio- 
plasty rvas pe&med from 9.4 to 10.6 days after enrollment 
and at a similar rate in the three moues (1.9% vs. 2.7% vs. 
1.9%. respectively), whereas co&$ bypass surgery was 
performed more frequently in patients with a longer history 
of angina (2.2% vs. 1.2% vs. 0.7%. respectively; (p < 
O.ooOl). Coronary bypass surgery was performed after 15.8 
? IO.1 days versus 13.9 c 10.4 days wrsus 14.4 + 10.5 days 
in the three groups, respectively (p = 0.07). When tite rites 
for coronary attgioplasty and bypass surgery were com- 
bined, a significantly higher rate was found among patients 
with antecedent angma than among patients without angina 
(3.9% to 4. I% vs. 2.6%, respectively) (p = 0.00021. 
Patienrs with a longer history of angina had a lower serum 
creatine kinase peak (1,078 f 1,373 IS. I,ED z 1,463 vs. 
1,350 f 1,534 Ill/liter, respectively) (p < O.OMll). were 
significnntly more likely to have early reinfarction and 
shock, stayed longer in the hospital and were discharged in 
a higher Fillip class than were patients in the olher two 
groups (Table 2;. 
During thu S-munlh fallowwp a& dischorge. patients 
with a longer history of angina had a significantly higher rate 
of reinfarction and underwent significantly more coronary 
bypass surgery (Table 3). 
Mortality (Fig. 1). Seven hundred fifleen patient; died 
before haspltal discharge: 287 (Ii!.l%) among the 2,370 
patients with antecedent angina for >I month, 135 (6.9%) 
among the I.512 patients with anrecedent angina for SI 
month and 293 (6.6%) among the 4,447 patients without 
antecedent angina (p 4 0.000~). Petien!s with a longer 
history of angina also had a higher mortality rate during the 
&month follow-up period after discharge. In a multivariate 
analysis taking into account all baseline characteristics, the 
r&&e r&k of muriaiiry assoctated wiih antecedenl angina 
was I .4 to 1.47 (p < 0.001). Both onivariate and muhivariate 
analyses revealed n similarly worse outcome for all patients 
with antecedent angina (irrespective of the angina duration) 
than that for patients without antecedent angina. 
Addilional baseline characteristics that were significanlly 
associated with a higher in-hospital mortality rate were: age 
>6il years and previous infarction or diabetes mellitus. 
Smoking was significantly associated with a lower mortality 
rate and this association was even more marked when only 
cardtavascular deaths acre cone:dered [Table 4). 
Discus&on 
Previous studier. Although several studies (6-12) have 
demonstrated that antecedent angina predicts a worse oul- 
come for patients with acw myocardial infarction. others 
(18,Zl) have emphasized its “protective” role in promoting 
the development of collateral circulation. Moreover, as 
rccentlg argued (22). myocardial preconditioning by short 
periods of ischemia leads to the synthesis of stress proteins 
(23) that protect the myocardium during subsequent isch- 
emia. Thus, despite significantly worse baseline characteris- 
tics and more severe coronary vessel disease in patients with 
‘Table 3. Clinical Outcome During 6.Monlh Follow-Up* 
5, Month >I Month 
AIlteEedenl *nIeceden, 
No Angma Angine ADgina 
(0 = 4.IlMI (II = I.JW (II = 2.0611 p valuet 
-.- 
Reinfarction 131 11.2) 67 (4.9) 129 (6.3, <O.m3oI 
Coronary angiopla0y 124 Il.0) 74 0.41 15 (I.61 0.01 
Coronary bywss surgery I61 (4.0) IO1 (7.4) IS9 (7 71 <@WI 
Cerebrovarculw e”enls 31 w3) l8(! 3) 24 (I.21 0.08 - 
‘Including patcn!s dirchalged akve and excludiag 148 patient5 with missing Followup data. tBy chi-square 
analysis for Wend. Unless olhcrw~c mdicated. data are expres*ep .x5 number ofpatizsls with percent efparicatr in 
parenlhese$ 
antecedent angina as compared with patients without a~ijcil. 
some investigaturs (15-17) have noted a better clinical out- 
cow in *~*+‘s with antecedent angina. ” . r” . . . . .
However, the definition of antecedent ang.na bar been 
inconsistent and it has been defined as occurring wi!h:n 24 h 
(13), within I week (10,14.15,17), within 2 wee!<s (71 or 
within I month (9.16) of the acute infarction. In addition. in 
some studies the group with antecedent angina included 
patients who had accelerating angina immediately before 
infarction whose baselme cowulation or coronwv oatho- 
logic findings might have differed. 
In a recent a alysis (IS) mcludin~ 778 tntwtts with acute 
myocardial infarction treated with thrombolytic therapy and 
early coronary angiography and angioplasty. the correlation 
between antecedent angina and outcome was evaluated. 
Antecedent angina pectoris was defined a? angina that 
started within : da;r c-f adni;sioc. f%+itc :heir hi&r risk 
profile a! entry, patients with antecedent angina had a lejs 
complicated in-hospital course than that of patients without 
antecedent angina. It was postulated thx the more frequerrt 
use ot beta-adrenerglc and ca!cium channel blockmg agccrs 
or .he protectwe role of collateral circulation :n these 
p&nii may have accounted for their surpnsmgly bcttcr 
O”ICO,IIS 
The p.rerent study. Although DW patient group was has!. 
calljj wmlar. our results contradict rhese findings. In our 
panems wrh antecedent angina. both whospiral and past- 
dixbwgc ouwome were significantly worse. These patien!s 
uwl ?ignificantiy more medical resonrces. stayed Ikmger m 
the hoavu! and uoderwent swtificantly mire coronary 
byparr operation than did patients without antecedent 
angma. These di%rences 8n revolts mey stem from the 
dniiering defimtions of antecedent angma pectoris. Thus. it IS 
important to note the increasing severity and intensity of 
complications anongthe three patient gruupr xitb izr;;;: :D 
the dxation of antecedent angina. 
Our patients with antecedent angina also had a greater 
mcidence of early and late reinfarction. Th!s finding. con- 
firmed by others (6.10). may be related to less complete 
reperfusion. as sueested by the lower peak creatme kinase 
values, or to more severe underlying coronary atheroscle- 
rotic disease in these patients, or both. 
ihe better outcorn; in patients who smoke IS surprising. 
Earlier studies (12.24-27) of patients with acute myoeardial 
infarction who were smokers repWed a higher survival rate 
for such oatients than for nonsmokers. In the TIMI- swdv 
(28) a lower mortality rate VW observed in current anb 
former smokers than in those who never smoked. Also in 
this study. orrent smokers had a loder incidence of rein- 
farc!ion than did former smokers and nonsmokers. Our 
group of nonsmokers did not include fomter smokers and 
:bus did not constitute a biased population of patients whc 
stopped smokmg because of deteno-mtirg health. The nature 
of coronary obstruction in patients whe smoke may be more 
thrombogenic and less atherogenic th?.n that of nonsmokers, 
and such patients mzy therefore be !eft with less GgniE.aa 
atheromarous r&dual stenosis after thrombolysir uherapeu- 
tic or spontaneous). 
The worse clinical outcome in our patients with anteced- 
ent angina may stem from the higher prevalence of multives- 
set coronary disease amor.g the>: patients (7.13-161. The 
rhilit., n< *ho n-,,b&ct zooe to become bype:$5:>etic 2nd !o “” . . . . . “. ..- ..” 
compens?.te for the impaired contractility of the infarct zone 
is :e?nced as the natdnfarct zone is subtended by coronary 
steno%. Indeed, failure to develop compensating hyper- 
tonesia in the noninfarct zone is more common among 
patients with multivessel disease than in those with single- 
vessel disease (29.30). The ability of the noninfarct zone to 
compensate for the dysfuxtiort of the infarct region may be 
critical for the survival of patients with acute myocardial 
infarction recebring thrombv!ytic therapy (31). The greater 
incidence of multivessel disease in pattents with antecedent 
angina thos makes them less likely :o dcvclop compensating 
hyperkinesia and is at least partially responsible for their 
pc~rer survival rares. !! remains !II be determiocd whether 
or not the clinical courx of there patients can be altered by 
combining thrombolytic therapy with more invasive manage- 
ment during acute hospitalization. 
Conclusions. Our results indicate that a history of axe- 
cedcnt angina pecbxis in patients with acute myocardial 
infarction receiving thnxbolytlc therapy predicts a wise 
clinical outcome and a more intense use of medical re- 
sources. 
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